Patents by Inventor Renee Kaswan

Renee Kaswan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treating exocrine gland atrophy
    Patent number: 5639743
    Abstract: Methods and compositions for the prevention or reversal of exocrine gland atrophy, especially lacrimal gland atrophy, by maintaining normal physiological levels of prolactin are described. In the preferred embodiment, exogenous prolactin or a substance that modulates endogenous prolactin secretion is administered to a mammal in combination with an androgen, such as testosterone. The combination acts synergistically to maintain or restore normal prolactin concentrations, resulting in the maintenance or restoration of gland mass and function. Administration of prolactin and androgen in combination with estrogen is particularly useful in the treatment of lacrimal gland dysfunction in post-menopausal women or women who have undergone ovariohysterectomies.
    Type: Grant
    Filed: June 30, 1994
    Date of Patent: June 17, 1997
    Assignees: University of Georgia Research Foundation, University of Southern California
    Inventors: Renee Kaswan, Austin K. Mircheff, Dwight W. Warren
  • Ocular cyclosporine composition
    Patent number: 5411952
    Abstract: Cyclosporine compositions for topical ophthalmic use for treatment of immune disorders, to enhance or restore tear production, and to enhance or effect normal healing of the surface of the eye, containing cyclosporine dissolved in corn oil. The composition may further include antioxidants, lubricants, antibiotics, antifungals, antivirals, pilocarpine, vasoconstrictors, surfactants, wetting agents, anti-inflammatory agents (i.e. corticosteroids), preservatives, mucolytic agents (i.e. bromhexine, acetylcysteine), as well as other compounds.The preferred composition is 2% cyclosporine, 1 mole % alpha tocopherol and 0.005% methyl paraben in corn oil.
    Type: Grant
    Filed: February 6, 1990
    Date of Patent: May 2, 1995
    Assignee: University of Georgia Research Foundation, Inc.
    Inventor: Renee Kaswan
  • Method of increasing tear production by topical administration of cyclosporin
    Patent number: 4839342
    Abstract: The present invention provides a method of treating an aqueous-deficient dry eye state in a patient suffering therefrom, which method includes the step of administering cyclosporin topically to the patient's eye. The cyclosporin is administered as a solution, suspension or ointment in a pharmaceutically acceptable excipient.
    Type: Grant
    Filed: September 3, 1987
    Date of Patent: June 13, 1989
    Assignee: University of Georgia Research Foundation, Inc.
    Inventor: Renee Kaswan
  • Ophthalmic treatment by topical administration of cyclosporin
    Patent number: 4649047
    Abstract: The present invention relates to a method for the treatment of either phacoanaphylactic endophthalmitis or uveitis by administering at least one cyclosporin topically to the eyes. Topical application of cyclosporin provides cyclosporin to the anterior chamber, the posterior chamber and the vitreous body of the eye.
    Type: Grant
    Filed: March 19, 1985
    Date of Patent: March 10, 1987
    Assignee: University of Georgia Research Foundation, Inc.
    Inventor: Renee Kaswan